Lyso-Gb3 modulates the gut microbiota and decreases butyrate production-Reference-Cited by-同舟云学术

Lyso-Gb3 modulates the gut microbiota and decreases butyrate production

Published:2019-08-19 Issue:1 Volume:9 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Aguilera-Correa John-Jairo^ORCID,Madrazo-Clemente Patricia,Martínez-Cuesta María del Carmen,Peláez Carmen,Ortiz Alberto^ORCID,Sánchez-Niño María Dolores,Esteban Jaime^ORCID,Requena Teresa

Funder

Ministry of Economy and Competitiveness | Instituto de Salud Carlos III

Comunidad de Madrid

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-019-48426-4.pdf

Reference87 articles.

1. Germain, D. P. Fabry disease. Orphanet journal of rare diseases 5, 30, https://doi.org/10.1186/1750-1172-5-30 (2010).

2. Ortiz, A. & Sanchez-Nino, M. D. Diagnosis and treatment of Fabry disease. Medicina clinica 148, 132–138, https://doi.org/10.1016/j.medcli.2016.09.047 (2017).

3. Germain, D. P. et al. Phenotypic characteristics of the p.Asn215Ser (p.N215S) GLA mutation in male and female patients with Fabry disease: A multicenter Fabry Registry study. Molecular genetics & genomic medicine, https://doi.org/10.1002/mgg3.389 (2018).

4. Ortiz, A. et al. Fabry disease revisited: Management and treatment recommendations for adult patients. Molecular genetics and metabolism 123, 416–427, https://doi.org/10.1016/j.ymgme.2018.02.014 (2018).

5. Wilcox, W. R. et al. Improvement of Fabry Disease-Related Gastrointestinal Symptoms in a Significant Proportion of Female Patients Treated with Agalsidase Beta: Data from the Fabry Registry. JIMD reports 38, 45–51, https://doi.org/10.1007/8904_2017_28 (2018).

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atypical Gut Microbiota Composition in a Mouse Model of Developmental Stuttering;2024-09-03

2. Plasma and platelet lipidome changes in Fabry disease;Clinica Chimica Acta;2024-08

3. Probiotics, gut microbiome, and cardiovascular diseases: An update;Transplant Immunology;2024-04

4. Gastrointestinal involvement in Fabry disease;Rare Disease and Orphan Drugs Journal;2024-03-29

5. A New 4-Thiazolidinone Derivative (Les-6490) as a Gut Microbiota Modulator: Antimicrobial and Prebiotic Perspectives;Antibiotics;2024-03-22